Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1,249 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Victoria Regional Health Centre
Barrie, Ontario, Canada
Sara J. RaskRecruiting - Waterloo Regional Health Network
Kitchener, Ontario, Canada
Nadia B. CalifarettiRecruiting - London Regional Cancer Program
London, Ontario, Canada
Veera Durga S. PanugantyRecruiting - Oakville Trafalgar Memorial Hospital
Oakville, Ontario, Canada
Michael HermanRecruiting - Lakeridge Health Oshawa
Oshawa, Ontario, Canada
Gursimran ChandhokeRecruiting - Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Carlos A. Carmona GonzalezRecruiting - Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
Saima HassanRecruiting - Jewish General Hospital
Montreal, Quebec, Canada
Parvaneh FallahRecruiting - Chu de Quebec-Hopital Du Saint-Sacrement (hss)
Québec, Quebec, Canada
Christine DesbiensRecruiting - Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, Canada
Michel PavicRecruiting - Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
Haji I. ChalchalRecruiting - Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
Shahid AhmedRecruiting
- Instituto Nacional de Cancerologia
Bogotá, Colombia
Suspended
- Ehime University Hospital
Tōon, Ehime, Japan
Yoshiaki KameiRecruiting - Hokkaido University Hospital
Sapporo, Hokkaido, Japan
Tomohiro OshinoRecruiting - Hyogo Cancer Center
Akashi, Hyōgo, Japan
Koji MatsumotoRecruiting - Gunma University Hospital
Gunma, Maebashi, Japan
Sayaka ObayashiRecruiting - the Cancer Institute Hospital of Jfcr
Koto-ku, Tokyo, Japan
Yukinori OzakiRecruiting - Hiroshima University Hospital
Hiroshima, Japan
Hideo ShigematsuRecruiting - Kyoto University Hospital
Kyoto, Japan
Norikazu MasudaRecruiting - Shikoku Cancer Center
Matsuyama, Japan
Daisuke TakabatakeRecruiting - Okayama University Hospital
Okayama, Japan
Tadahiko ShienRecruiting - Saitama Medical University International Medical Center
Saitama, Japan
Akihiro FujimotoRecruiting - Nagoya University Hospital
Showa-Ku Nagoya, Japan
Yuko TakanoRecruiting - National Cancer Center Hospital
Tokyo, Japan
Shin TakayamaRecruiting
- Instituto Nacional de Cancerologia de Mexico
Mexico City, Tlalpan, Mexico
Areli Velazquez MartinezRecruiting
- Instituto Nacional de Enfermedades Neoplasicas
Lima, Peru
Suspended
- Cancer Center-Metro Medical Center Bayamon
Bayamón, Puerto Rico
Suspended - Puerto Rico Hematology Oncology Group
Bayamón, Puerto Rico
Luis J. Santos ReyesRecruiting - Doctors Cancer Center
Manati, Puerto Rico
Luis J. Santos ReyesRecruiting - Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
Luis J. Santos ReyesRecruiting - Proncology
San Juan, Puerto Rico
Luis J. Santos ReyesRecruiting - San Juan City Hospital
San Juan, Puerto Rico
Luis J. Santos ReyesRecruiting - San Juan Community Oncology Group
San Juan, Puerto Rico
Luis J. Santos ReyesRecruiting
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
Active, not recruiting - Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
Dan S. ZuckermanRecruiting - Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
Dan S. ZuckermanRecruiting - Alaska Women'S Cancer Care
Anchorage, Alaska, United States
Dan S. ZuckermanRecruiting - Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
Dan S. ZuckermanRecruiting - Anchorage Oncology Centre
Anchorage, Alaska, United States
Suspended
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Oct 2023
- Primary completion
- 31 Jan 2032
- Completion
- 31 Jul 2034
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 3,960
- Registry id
- NCT05879926
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.